Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Clinical Genitourinary Cancer
|
July 23, 2016
Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype
Solene-Florence Kammerer-Jacquet, Angelique Brunot, Adelaide Pladys, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 13, 2014
Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances
Florian Cabillic, Audrey Gros, Frédéric Dugay, et al.
Clinical Genitourinary Cancer
|
March 7, 2019
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression
Solène-Florence Kammerer-Jacquet, Angelique Brunot, Mathilde Lefort, et al.
Urologic Oncology
|
June 17, 2017
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
Solène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, et al.
International Journal of Clinical Oncology
|
March 28, 2020
Implementation of a molecular tumor board at a regional level to improve access to targeted therapy
Héloïse Bourien, Alexandra Lespagnol, Boris Campillo-Gimenez, et al.
Targeted Oncology
|
May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy
Solène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2021
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies
Florence Koeppel, Etienne Muller, Alexandre Harlé, et al.
International Journal of Cancer
|
September 14, 2016
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential
Solène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, et al.
EMBO Reports
|
March 29, 2024
TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling
Robert Amson, Andrea Senff-Ribeiro, Teele Karafin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2021
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stéphane Terry, Cécile Dalban, Nathalie Rioux-Leclercq, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Clinical Genitourinary Cancer
|
July 23, 2016
Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype
Solene-Florence Kammerer-Jacquet, Angelique Brunot, Adelaide Pladys, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 13, 2014
Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances
Florian Cabillic, Audrey Gros, Frédéric Dugay, et al.
Clinical Genitourinary Cancer
|
March 7, 2019
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression
Solène-Florence Kammerer-Jacquet, Angelique Brunot, Mathilde Lefort, et al.
Urologic Oncology
|
June 17, 2017
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
Solène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, et al.
International Journal of Clinical Oncology
|
March 28, 2020
Implementation of a molecular tumor board at a regional level to improve access to targeted therapy
Héloïse Bourien, Alexandra Lespagnol, Boris Campillo-Gimenez, et al.
Targeted Oncology
|
May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy
Solène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2021
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies
Florence Koeppel, Etienne Muller, Alexandre Harlé, et al.
International Journal of Cancer
|
September 14, 2016
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential
Solène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, et al.
EMBO Reports
|
March 29, 2024
TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling
Robert Amson, Andrea Senff-Ribeiro, Teele Karafin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2021
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stéphane Terry, Cécile Dalban, Nathalie Rioux-Leclercq, et al.
Page
of 4